News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
CRISPR Corrects RNA-based Disease Defects
Kerry Grens | Aug 10, 2017
In human cells, researchers deploy the genome editor to snip out toxic repetitive sequences.
Additional #IceBucketChallenge Payoffs
Jef Akst | Jul 28, 2016
Researchers identify a new ALS-associated gene thanks to funds generated by the social media challenge that went viral in summer 2014.
Arthur L. Caplan | Mar 22, 2016
At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.
Staff | Oct 1, 2015
Harvard Professor Marc Weisskopf discusses the potential link between formaldehyde and ALS.
Jef Akst | Oct 1, 2015
Data on the links between ALS and the chemical have been contradictory, but the latest study suggests undertakers are at risk.
ALS Drug Access Debated
Jef Akst | Apr 7, 2015
Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.
Aimee Swartz | Mar 1, 2015
Statisticians who normally crunch numbers to forecast trends in the food-service industry turn their attention to bettering treatment of ALS.
#IceBucketChallenge Highlights Difficult Funding Decisions
Jef Akst | Sep 3, 2014
The ALS Association has raised more than $100 million in donations through a charity campaign that went viral. How should that money be spent?
Ice Bucket Challenge Irony
Bob Grant | Aug 25, 2014
Several US legislators who voted in favor of a bill that cut federal funding for ALS research have taken the chilly plunge for charity.
Non-coding Repeats Cause Peptide Clumps
Ruth Williams | Feb 7, 2013
Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.